Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Solution Solution/ Drops
Product Images NDC 72162-2381

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Solution (NDC 72162-2381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dorzolamide Structure (Dorzotimo Dorzolamidestrc)

FDA Label Image

Figure B (Dorzotimo Figreb)

FDA Label Image

Fig A (Dorzotimo Figurea)

FDA Label Image

Timolol Structure (Dorzotimo Timololstrct)

FDA Label Image

Label (Lbl721622381)

Label (Lbl721622381)
This is a description for a pharmaceutical product containing Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution. Each mL contains 22.3 mg of Dorzolamide Hydrochloride (equivalent to 20 mg of Dorzolamide) and 6.8 mg of Timolol Maleate (equivalent to 5 mg of Timolol). It also includes inactive ingredients such as Hydroxyethyl Cellulose, Mannitol, Trisodium Citrate Dihydrate, and Benzalkonium chloride as a preservative. The product is sterile when manufactured and should be used only for the eyes. It is advised to store between 20° to 25°C and protect from light. Patients are instructed to read the package insert for dosage information and should follow the instructions to avoid contamination.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.